VRCA
NASDAQ · Pharmaceuticals
Verrica Pharmaceuticals Inc
$6.27
-0.10 (-1.57%)
Open$6.39
Previous Close$6.37
Day High$6.58
Day Low$6.15
52W High$9.82
52W Low$3.28
Volume—
Avg Volume109.4K
Market Cap140.42M
P/E Ratio—
EPS$-1.61
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+53.0% upside
Current
$6.27
$6.27
Target
$9.59
$9.59
$7.88
$9.59 avg
$13.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 74.80M | 47.36M | 35.73M |
| Net Income | -37,605,252 | -21,428,850 | 6.74M |
| Profit Margin | -50.3% | -47.8% | 18.9% |
| EBITDA | -27,827,125 | -16,737,855 | 12.85M |
| Free Cash Flow | — | — | 8.80M |
| Rev Growth | +57.9% | +57.9% | +7.9% |
| Debt/Equity | 0.04 | 0.04 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |